Company Overview

PRIME exits and American HealthCare Capital are pleased to exclusively introduce a pioneering technology company in the rapidly expanding digital therapeutics sector that has developed a breakthrough AI-powered platform that addresses critical gaps in mental healthcare delivery. Operating at the intersection of robotics, artificial intelligence, and clinical psychology, this innovative enterprise has created a comprehensive solution combining physical hardware and software applications to provide personalized therapeutic interventions.

The company’s proprietary technology platform leverages patented, advanced natural language processing, machine learning algorithms, and biofeedback monitoring to deliver evidence-based therapeutic protocols. The solution addresses the significant treatment gap in mental healthcare, where traditional service delivery models fail to meet growing demand due to cost, accessibility, and stigma barriers.

With proven market traction demonstrated through substantial revenue generation and international sales across multiple continents, the company has established manufacturing capabilities, distribution partnerships, and clinical validation through institutional partnerships. The experienced management team combines deep technical expertise with clinical credentials and proven track records in healthcare entrepreneurship.

Financial Overview

The company demonstrated a positive Net Profit in FY2024. In FY2025, the projected Gross Revenue is $550,000 with a Net Profit of $215,000 (39%), as resources are deployed for growth. The FY2025 projections are based on outstanding contracts, accounts receivable, and the existing pipeline.

Profitability is expected to grow in FY2026 as operational efficiencies and scale benefits materialize. Growth can be even faster if the right capital is injected into the business to support manufacturing.

The Opportunity

The company seeks growth capital to scale manufacturing operations, expand market reach, and accelerate product development initiatives that will solidify its competitive positioning in this emerging market segment.

This represents a unique opportunity to participate in a technology-enabled healthcare solution with demonstrated clinical efficacy, established intellectual property protection, and significant market expansion potential across multiple demographic segments and geographic regions.